Related Experiment Video
Updated: Jan 10, 2026
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet Recovery and Coexisting Conditions in Pediatric Immune Thrombocytopenia: Insights from a Tertiary Care Study
Cristina Elena Singer1, Mocanu Andreea Gabriela2, Sîrbuleț Carmen3
1Department of Mother and Baby, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Insights
Pediatric immune thrombocytopenia (ITP) often affects young children and may present with concurrent conditions. Standard first-line therapy effectively promotes platelet recovery by hospital discharge in these children.
Area of Science:
- Pediatric Hematology
- Immunology
- Clinical Research
Background:
- Immune thrombocytopenia (ITP) is a rare but significant hematologic disorder in children.
- While most pediatric ITP cases resolve spontaneously, some require intervention with variable treatment responses.
- Characterizing presentation and response is crucial for effective management.
Purpose of the Study:
- To characterize the clinical presentation of newly diagnosed pediatric ITP.
- To identify coexisting conditions in hospitalized children with ITP.
- To assess short-term platelet response to first-line therapy.
Main Methods:
- Retrospective, three-year observational cohort study.
- Inclusion of 100 children (5 months-17 years) diagnosed with ITP.
- Data collection on demographics, presentation, laboratory results, and outcomes at discharge.
Main Results:
- Balanced urban-rural distribution; sex distribution varied by residence.
- Over 40% of patients were under 5 years old.
- Nearly all children showed substantial platelet count recovery by hospital discharge with first-line therapy; concurrent conditions were noted but not causative.
Conclusions:
- Pediatric ITP often presents in young children with concurrent conditions.
- Standard first-line treatment leads to robust platelet recovery by discharge.
- Comprehensive initial evaluation and supportive care are vital for managing pediatric ITP.
Background/Objectives:
Immune thrombocytopenia (ITP) is a rare but significant hematologic disorder in children. While most pediatric ITP cases resolve spontaneously, some require intervention, and treatment responses with platelet recovery patterns can vary widely. We conducted a retrospective, three-year observational cohort study including 100 children (aged 5 months-17 years) diagnosed with ITP at a single tertiary center (January 2022-December 2024). The primary objective of this study was to characterize the clinical presentation, coexisting conditions, and short-term platelet response to first-line therapy in hospitalized children with newly diagnosed ITP.
Methods:
Clinical data (demographics, presentation, and laboratory results) were collected at admission and throughout hospitalization, and outcomes were assessed at discharge.
Results:
Our analysis showed a balanced urban-rural distribution overall; however, sex distribution differed by residence, with a slight female predominance in rural areas and an overwhelming male predominance in urban areas. Over 40% of patients were under 5 years old. Platelet counts at presentation ranged from 3 × 109/L to 30 × 109/L, yet nearly all children showed substantial platelet count recovery by hospital discharge under first-line therapy. Most patients had additional minor clinical findings at admission, but these were considered concurrent rather than causative factors, in accordance with current hematology guidelines. These conditions were considered coexisting clinical conditions or concurrent findings rather than definitive secondary causes of ITP, in accordance with established hematological guidelines. These findings reflect only short-term, in-hospital outcomes and may not be generalizable to all children with ITP, particularly milder or outpatient cases.
Conclusions:
Our three-year cohort study underscores that pediatric ITP often presents in very young children with concurrent conditions, but standard first-line treatment leads to robust platelet recovery by discharge. These findings highlight the importance of comprehensive initial evaluation and supportive care in managing pediatric ITP.
